Your browser doesn't support javascript.
loading
Author Correction: A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma.
Kjeldsen, Julie Westerlin; Lorentzen, Cathrine Lund; Martinenaite, Evelina; Ellebaek, Eva; Donia, Marco; Holmstroem, Rikke Boedker; Klausen, Tobias Wirenfeldt; Madsen, Cecilie Oelvang; Ahmed, Shamaila Munir; Weis-Banke, Stine Emilie; Holmström, Morten Orebo; Hendel, Helle Westergren; Ehrnrooth, Eva; Zocca, Mai-Britt; Pedersen, Ayako Wakatsuki; Andersen, Mads Hald; Svane, Inge Marie.
Affiliation
  • Kjeldsen JW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Lorentzen CL; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Martinenaite E; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Ellebaek E; IO Biotech Aps, Copenhagen, Denmark.
  • Donia M; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Holmstroem RB; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Klausen TW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Madsen CO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Ahmed SM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Weis-Banke SE; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Holmström MO; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Hendel HW; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
  • Ehrnrooth E; Department of Clinical Physiology and Nuclear Medicine, Copenhagen University Hospital, Herlev, Denmark.
  • Zocca MB; IO Biotech Aps, Copenhagen, Denmark.
  • Pedersen AW; IO Biotech Aps, Copenhagen, Denmark.
  • Andersen MH; IO Biotech Aps, Copenhagen, Denmark.
  • Svane IM; National Center for Cancer Immune Therapy (CCIT-DK), Department of Oncology, Copenhagen University Hospital, Herlev, Denmark.
Nat Med ; 28(4): 871, 2022 Apr.
Article in En | MEDLINE | ID: mdl-35260843
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Document type: Article Affiliation country:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Nat Med Journal subject: BIOLOGIA MOLECULAR / MEDICINA Year: 2022 Document type: Article Affiliation country: